泰山医学院学报
泰山醫學院學報
태산의학원학보
JOURNAL OF TAISHAN MEDICAL COLLEGE
2014年
5期
349-351
,共3页
食管鳞癌%榄香烯注射液%长春瑞滨%调强放疗
食管鱗癌%欖香烯註射液%長春瑞濱%調彊放療
식관린암%람향희주사액%장춘서빈%조강방료
esophageal squamous cell carcinoma%Elemene%vinorelbine%IMRT
目的:观察榄香烯注射液联合单药长春瑞滨同步调强放疗治疗老年中晚期食管鳞癌的近期疗效和不良反应。方法80例老年食管鳞癌患者随机分为单纯调强放疗组(简称单放组)和榄香烯注射液联合单药长春瑞滨同步调强放疗组(联合组),每组各40例病人。两组患者调强放射治疗方法相同,放疗总剂量60~66 Gy。联合组每日放疗前2 h 予榄香烯200 mg 加入5%葡萄糖溶液100 ml 静脉滴注,长春瑞滨( NVB)25 mg/!,第1、8天,21天为一个周期,同步放疗连续化疗2周期。结果联合组患者近期有效率为92.5%,明显高于单放组的75%(P ﹤0.05),两组不良反应发生率无显著性差异。结论对于老年中晚期食管鳞癌患者,可采用榄香烯注射液联合单药长春瑞滨同步调强放疗的治疗方法,有较好的近期疗效,不良反应并未明显增加,远期疗效需进一步观察。
目的:觀察欖香烯註射液聯閤單藥長春瑞濱同步調彊放療治療老年中晚期食管鱗癌的近期療效和不良反應。方法80例老年食管鱗癌患者隨機分為單純調彊放療組(簡稱單放組)和欖香烯註射液聯閤單藥長春瑞濱同步調彊放療組(聯閤組),每組各40例病人。兩組患者調彊放射治療方法相同,放療總劑量60~66 Gy。聯閤組每日放療前2 h 予欖香烯200 mg 加入5%葡萄糖溶液100 ml 靜脈滴註,長春瑞濱( NVB)25 mg/!,第1、8天,21天為一箇週期,同步放療連續化療2週期。結果聯閤組患者近期有效率為92.5%,明顯高于單放組的75%(P ﹤0.05),兩組不良反應髮生率無顯著性差異。結論對于老年中晚期食管鱗癌患者,可採用欖香烯註射液聯閤單藥長春瑞濱同步調彊放療的治療方法,有較好的近期療效,不良反應併未明顯增加,遠期療效需進一步觀察。
목적:관찰람향희주사액연합단약장춘서빈동보조강방료치료노년중만기식관린암적근기료효화불량반응。방법80례노년식관린암환자수궤분위단순조강방료조(간칭단방조)화람향희주사액연합단약장춘서빈동보조강방료조(연합조),매조각40례병인。량조환자조강방사치료방법상동,방료총제량60~66 Gy。연합조매일방료전2 h 여람향희200 mg 가입5%포도당용액100 ml 정맥적주,장춘서빈( NVB)25 mg/!,제1、8천,21천위일개주기,동보방료련속화료2주기。결과연합조환자근기유효솔위92.5%,명현고우단방조적75%(P ﹤0.05),량조불량반응발생솔무현저성차이。결론대우노년중만기식관린암환자,가채용람향희주사액연합단약장춘서빈동보조강방료적치료방법,유교호적근기료효,불량반응병미명현증가,원기료효수진일보관찰。
Objective:To investigate the efficacy and side effects of elemene injection and vinorelbine combined with Intensity Modulated Radiation Therapy(IMRT)treatment for elder patients with advanced squamous cell carcinoma. Meth-ods:Eighty elder patients with advanced esophageal squamous cell carcinoma were randomly divided into pure intensity modulated radiotherapy( radiation group )and elemene injection with vinorelbine combined with IMRT group(combination group),with 40 patients in each group. Intensity modulation radiotherapy was applied in the two groups of patients with a total dose of 60 ~ 66Gy. Combination group were injected with elemene injection(200mg elemene was dissolved in 5% glu-cose solution 100 mL)before radiotherapy every day intravenously,vinorelbine(NVB)was given 25 mg / m 2 on d1 and d8 with 21 days as a cycle for 2 cycles. Results:In the combination group,the effective rate was 92. 5% ,while that of ra-diation group was 75% . The effective rates of the two groups had statistic significances(χ2 = 4. 501,P ﹤ 0. 05). The major adverse effects in the two groups had no significant difference. Conclusion:For elder patients with advanced esophageal squamous cell carcinoma,Elemene injection and vinorelbine combined with IMRT can improve their recent effective rates, the adverse effects can be accepted and the long - term effects need to be further observed.